FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2009/091/000761 [Registered on: 07/10/2009]
Last Modified On: 20/01/2012
Post Graduate Thesis   
Type of Trial   
Type of Study    
Study Design  Non-randomized, Placebo Controlled Trial 
Public Title of Study   A clinicalm trial to study the effects of a herbal drug Dawa-e-Musakkin in patients with anxity and Tension 
Scientific Title of Study   A Clinical Study of Dawa-e- Musakkin in the treatment of Generalized Anxiety Disorder (GAD). 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yasmeen Shamsi 
Designation   
Affiliation   
Address  Clinical Research Unit, Majeedia Hospital
Jamia Hamdard
New Delhi
DELHI
110062
India 
Phone  01126059692, Ext. 5930, 5723  
Fax  26059663  
Email  yasmeen.ijum@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Yasmeen Shamsi 
Designation   
Affiliation   
Address  Clinical Research Unit, Majeedia Hospital
Jamia Hamdard
New Delhi
DELHI
110062
India 
Phone  01126059692, Ext. 5930, 5723  
Fax  26059663  
Email  yasmeen.ijum@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Yasmeen Shamsi 
Designation   
Affiliation   
Address  Clinical Research Unit, Majeedia Hospital
Jamia Hamdard
New Delhi
DELHI
110062
India 
Phone  01126059692, Ext. 5930, 5723  
Fax  26059663  
Email  yasmeen.ijum@gmail.com  
 
Source of Monetary or Material Support  
Hamdard National Foundation, New Delhi and Jamia Hamdard, New Delhi 
 
Primary Sponsor  
Name  Hamdard National Foundation, New Delhi  
Address   
Type of Sponsor   
 
Details of Secondary Sponsor  
Name  Address 
Jamia Hamdard, New Delhi   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Yasmeen Shamsi  Clinical Research Unit, Majeedia Hospital  Majeedia Hospital,Jamia Hamdard-110062
New Delhi
DELHI 
011-26059692, Ext. 5930
26059663
yasmeen.ijum@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee, Jamia Hamdard  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Generalized Anxiety Disorder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dawa-e-Musakkin  2 gram OD for 3 months  
Comparator Agent  placebo  2 gram OD for 3 months  
 
Inclusion Criteria  
Age From   
Age To   
Gender   
Details  ?Age and Sex- 18-60 years, either sex ?Patients diagnosed as cases of generalized anxiety disorder according to DSM-IV diagnostic Criteria  
 
ExclusionCriteria 
Details  ?Pregnancy or lactation ?Women patients above 45 years of age( Post menopausal women) ?Patients with past or current history of cigarette smoking, drug or alcohol abuse. ?Patients of hyperthyroidism or hypothyroidism. ?Patients with a history of hypoglycemic episodes. ?Any cardiovascular /or chest diseases  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in mean Hamilton Anxiety Rating score  4,8,12 week 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in performance  3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)
Modification(s)  
01/03/2003 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  01/03/2003 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Tis study is a randomized , double blind parallel group trial comparing tthe efficacy of a herbal drug Dawa-e-Musakkin 2 gram daily with Placebo 2 gram daily in 50 patients of Generalized Anxiety Disorder for 3 months. 
Close